157.82
price down icon1.79%   -2.88
after-market After Hours: 157.84 0.02 +0.01%
loading

Vaneck Biotech Etf Stock (BBH) Forecast

The Vaneck Biotech Etf (BBH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $176.47, representing a +11.82% increase from the current price of $157.82. The highest analyst price target is $182.08, and the lowest is $170.86.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBH Price Target
Average 185.39 (+17.47% Upside)
loading

Is Vaneck Biotech Etf (BBH) A Buy Now?

Oscillators
Name Value Action
RSI(14) 40.98 Neutral
STOCH(9,6) 67.56 Neutral
STOCHRSI(14) 54.54 Neutral
MACD(12,26) -1.4456 Buy
ADX(14) 21.99 Neutral
William %R -63.65 Neutral
CCI(14) -0.1326 Neutral
Buy: 1 Sell: 0 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
158.67
Sell
159.22
Sell
MA20
159.30
Sell
160.05
Sell
MA50
163.78
Sell
163.64
Sell
MA100
170.59
Sell
167.00
Sell
MA200
169.33
Sell
167.42
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, BBH could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on BBH, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 40.98 indicates that BBH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 67.56 indicates that BBH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 54.54 indicates that BBH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 21.99 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -0.1326 indicates that BBH is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term BBH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Vaneck Biotech Etf financial reports and earnings history, Vaneck Biotech Etf (BBH) stock could reach $199.46 by 2030, $309.00 by 2040 and $385.01 by 2050. See the projected annual prices until 2050 of the Vaneck Biotech Etf stock below:

  • Vaneck Biotech Etf (BBH) is expected to reach an average price of $248.73 in 2035, with a high prediction of $250.36 and a low estimate of $239.51. This indicates an $57.60% rise from the last recorded price of $157.82.
  • Vaneck Biotech Etf (BBH) stock is projected to chart a bullish course in 2040, with an average price target of $301.59, representing an $91.10% surge from its current level. The forecast ranges from a conservative $298.46 to a sky-high $309.00.
  • Our analysts predict Vaneck Biotech Etf (BBH) to jump 107.13% by 2045, soaring from $320.41 to an average price of $326.89, potentially reaching $337.49. While $320.41 is the low estimate, the potential upside is significant.
  • Vaneck Biotech Etf (BBH) stock is expected to climb by 2050, reaching an average of $384.99, a $143.94% jump from its current level. However, a wide range of estimates exists, with high and low targets of $385.01 and $369.76, respectively, highlighting the market's uncertainty.

Vaneck Biotech Etf Stock (BBH) Year by Year Forecast

Vaneck Biotech Etf Stock (BBH) Price Forecast for 2025

Vaneck Biotech Etf Stock (BBH) is expected to reach an average price of $185.39 in 2025, with a high prediction of $218.83 and a low estimate of $151.95. This indicates an +17.47% rise from the last recorded price of $157.82.
Month Average Low High Change from today's price
February, 2025 $171.57 $170.86 $182.08 +8.71%
March, 2025 $170.91 $168.93 $184.72 +8.29%
April, 2025 $166.88 $151.95 $180.85 +5.74%
May, 2025 $191.62 $162.88 $193.59 +21.42%
June, 2025 $198.20 $184.95 $200.79 +25.58%
July, 2025 $205.78 $189.23 $205.78 +30.39%
August, 2025 $207.67 $200.34 $210.11 +31.59%
September, 2025 $204.93 $203.37 $218.83 +29.85%
October, 2025 $195.79 $192.84 $205.53 +24.06%
November, 2025 $203.26 $191.68 $204.22 +28.79%
December, 2025 $193.68 $191.90 $211.00 +22.72%

Vaneck Biotech Etf Stock (BBH) Price Forecast for 2026

The predicted value for Vaneck Biotech Etf (BBH) in 2026 is set at an average of $228.81. Estimates vary from a peak of $265.38 to a trough of $192.23, indicating an +44.98% surge from the present price of $157.82.
Month Average Low High Change from today's price
January, 2026 $206.56 $192.23 $207.97 +30.88%
February, 2026 $218.81 $207.78 $219.19 +38.65%
March, 2026 $222.84 $208.70 $223.87 +41.20%
April, 2026 $230.94 $222.60 $239.35 +46.33%
May, 2026 $220.88 $205.78 $230.32 +39.96%
June, 2026 $219.31 $210.70 $224.55 +38.96%
July, 2026 $220.29 $214.09 $234.51 +39.59%
August, 2026 $241.46 $218.28 $243.91 +52.99%
September, 2026 $243.17 $233.48 $246.54 +54.08%
October, 2026 $257.42 $236.88 $262.49 +63.11%
November, 2026 $259.40 $248.95 $265.38 +64.37%
December, 2026 $245.97 $244.51 $263.33 +55.86%

Vaneck Biotech Etf Stock (BBH) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Vaneck Biotech Etf (BBH) is $211.47, with a high forecast of $246.60 and a low forecast of $176.34. This indicates an +33.99% increase from the last price of $157.82.
Month Average Low High Change from today's price
January, 2027 $239.81 $233.45 $242.66 +51.95%
February, 2027 $237.14 $231.40 $246.60 +50.26%
March, 2027 $238.44 $224.65 $244.66 +51.08%
April, 2027 $217.79 $214.63 $239.69 +38.00%
May, 2027 $208.62 $197.64 $214.66 +32.19%
June, 2027 $197.20 $192.26 $212.89 +24.95%
July, 2027 $206.83 $191.46 $211.40 +31.05%
August, 2027 $199.16 $199.16 $213.26 +26.19%
September, 2027 $196.54 $178.43 $200.49 +24.54%
October, 2027 $181.93 $176.34 $196.12 +15.28%
November, 2027 $202.39 $183.24 $203.46 +28.24%
December, 2027 $206.07 $193.70 $209.26 +30.57%

Vaneck Biotech Etf Stock (BBH) Price Forecast for 2028

In 2028, Vaneck Biotech Etf (BBH) is projected to reach an average price of $199.68, with a high projection of $216.69 and a low estimate of $182.67. This indicates an +26.52% rise from the last price of $157.82.
Month Average Low High Change from today's price
January, 2028 $191.11 $190.14 $209.28 +21.09%
February, 2028 $186.69 $182.67 $200.26 +18.29%
March, 2028 $203.34 $186.94 $204.11 +28.85%
April, 2028 $211.69 $199.41 $214.61 +34.14%
May, 2028 $208.63 $205.80 $216.69 +32.20%
June, 2028 $214.13 $203.80 $215.91 +35.68%
July, 2028 $209.53 $209.00 $216.34 +32.77%
August, 2028 $198.32 $197.34 $212.35 +25.67%
September, 2028 $212.33 $199.55 $212.42 +34.54%
October, 2028 $207.95 $203.88 $214.59 +31.76%
November, 2028 $205.62 $201.38 $209.65 +30.29%
December, 2028 $203.74 $201.28 $210.01 +29.10%

Vaneck Biotech Etf Stock (BBH) Price Forecast for 2029

The 2029 price forecast for Vaneck Biotech Etf Stock (BBH) is $205.52 on average, with a high prediction of $220.03 and a low estimate of $191.01. This represents an +30.23% increase from the previous price of $157.82.
Month Average Low High Change from today's price
January, 2029 $208.67 $200.27 $211.63 +32.22%
February, 2029 $210.01 $205.40 $211.79 +33.07%
March, 2029 $208.46 $208.13 $213.65 +32.09%
April, 2029 $205.21 $200.58 $209.07 +30.03%
May, 2029 $196.30 $191.01 $205.59 +24.38%
June, 2029 $202.39 $194.72 $202.39 +28.24%
July, 2029 $214.22 $201.33 $216.25 +35.73%
August, 2029 $214.61 $213.17 $220.03 +35.98%
September, 2029 $215.06 $207.39 $216.57 +36.27%
October, 2029 $214.66 $211.95 $217.04 +36.02%
November, 2029 $201.99 $200.98 $216.62 +27.99%
December, 2029 $196.54 $194.27 $209.76 +24.53%

Vaneck Biotech Etf Stock (BBH) Price Forecast for 2030

Vaneck Biotech Etf Stock (BBH) is expected to reach an average price of $208.11 in 2030, with a high forecast of $224.44 and a low forecast of $191.77. This signifies an +31.86% surge from the last price of $157.82.
Month Average Low High Change from today's price
January, 2030 $196.58 $192.21 $199.46 +24.56%
February, 2030 $201.55 $196.42 $207.51 +27.71%
March, 2030 $203.04 $200.95 $205.69 +28.65%
April, 2030 $200.08 $198.74 $204.20 +26.77%
May, 2030 $195.76 $194.61 $202.01 +24.04%
June, 2030 $202.26 $191.77 $203.66 +28.16%
July, 2030 $216.05 $202.22 $216.05 +36.90%
August, 2030 $221.45 $216.32 $221.48 +40.32%
September, 2030 $220.93 $216.01 $221.71 +39.99%
October, 2030 $222.47 $210.46 $222.74 +40.96%
November, 2030 $201.37 $196.35 $224.44 +27.60%
December, 2030 $207.57 $191.88 $210.01 +31.52%
exchange_traded_fund VTV
$170.56
price up icon 0.78%
exchange_traded_fund VUG
$403.83
price down icon 0.42%
exchange_traded_fund IJH
$63.10
price up icon 1.17%
exchange_traded_fund EFA
$75.12
price up icon 0.36%
exchange_traded_fund IWF
$395.30
price down icon 0.35%
exchange_traded_fund QQQ
$505.08
price down icon 0.09%
Cap:     |  Volume (24h):